Cargando…

Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study

OBJECTIVES: This study was aimed to determine the level of glycaemic control and associated factors in patients with type 2 diabetes mellitus (T2DM) treated with insulin-based therapy. DESIGNS: Institutional-based multicentre cross-sectional study design was employed to conduct this study. SETTINGS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Sendekie, Ashenafi Kibret, Belachew, Eyayaw Ashete, Dagnew, Ephrem Mebratu, Netere, Adeladlew Kassie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454077/
https://www.ncbi.nlm.nih.gov/pubmed/36691186
http://dx.doi.org/10.1136/bmjopen-2022-065250
_version_ 1784785273971802112
author Sendekie, Ashenafi Kibret
Belachew, Eyayaw Ashete
Dagnew, Ephrem Mebratu
Netere, Adeladlew Kassie
author_facet Sendekie, Ashenafi Kibret
Belachew, Eyayaw Ashete
Dagnew, Ephrem Mebratu
Netere, Adeladlew Kassie
author_sort Sendekie, Ashenafi Kibret
collection PubMed
description OBJECTIVES: This study was aimed to determine the level of glycaemic control and associated factors in patients with type 2 diabetes mellitus (T2DM) treated with insulin-based therapy. DESIGNS: Institutional-based multicentre cross-sectional study design was employed to conduct this study. SETTINGS: The diabetes follow-up clinics of selected hospitals in Northwest Ethiopia. PARTICIPANTS: Adult patients with T2DM treated with insulin-based therapy at the selected hospitals who met the eligibility criteria were the study participants. MAIN OUTCOME MEASURES: Good glycaemic control; when fasting blood glucose (FBG) level ranged from 70 to 130 mg/dL, and FBG <70 and >130 mg/dL was considered poor glycaemic control. A logistic regression model was used to identify determinants of poor glycaemic control. A p<0.05 at 95% CI was statistically significant. RESULTS: Of 403 study participants, 54.8% were males with a mean age of 55.03±10.8 years. Though patients with T2DM were treated with insulin-based therapy, most of the participants (72.5%) could not achieve the target FBG. The overall mean FBG was 177.1±54.3, and far from the target glucose level. Patients who could not practise self-monitoring of blood glucose were found more likely to have poor glycaemic control compared with those who practised self-monitoring (p<0.001). Whereas patients who had a normal body mass index (p=0.011) and who were treated with premixed insulin-based therapy (p=0.04) were found less likely to have poor glycaemic control compared with patients with obesity and who received NPH insulin based-regimens, respectively. CONCLUSION: This study demonstrated that a significant proportion of the study samples could not achieve glycaemic targets and the average blood glucose was far higher than the recommended glycaemic target level. Insulin initiation and titration, considering the determinants of glycaemic control, could be recommended to achieve target glycaemic levels.
format Online
Article
Text
id pubmed-9454077
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-94540772022-09-14 Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study Sendekie, Ashenafi Kibret Belachew, Eyayaw Ashete Dagnew, Ephrem Mebratu Netere, Adeladlew Kassie BMJ Open Diabetes and Endocrinology OBJECTIVES: This study was aimed to determine the level of glycaemic control and associated factors in patients with type 2 diabetes mellitus (T2DM) treated with insulin-based therapy. DESIGNS: Institutional-based multicentre cross-sectional study design was employed to conduct this study. SETTINGS: The diabetes follow-up clinics of selected hospitals in Northwest Ethiopia. PARTICIPANTS: Adult patients with T2DM treated with insulin-based therapy at the selected hospitals who met the eligibility criteria were the study participants. MAIN OUTCOME MEASURES: Good glycaemic control; when fasting blood glucose (FBG) level ranged from 70 to 130 mg/dL, and FBG <70 and >130 mg/dL was considered poor glycaemic control. A logistic regression model was used to identify determinants of poor glycaemic control. A p<0.05 at 95% CI was statistically significant. RESULTS: Of 403 study participants, 54.8% were males with a mean age of 55.03±10.8 years. Though patients with T2DM were treated with insulin-based therapy, most of the participants (72.5%) could not achieve the target FBG. The overall mean FBG was 177.1±54.3, and far from the target glucose level. Patients who could not practise self-monitoring of blood glucose were found more likely to have poor glycaemic control compared with those who practised self-monitoring (p<0.001). Whereas patients who had a normal body mass index (p=0.011) and who were treated with premixed insulin-based therapy (p=0.04) were found less likely to have poor glycaemic control compared with patients with obesity and who received NPH insulin based-regimens, respectively. CONCLUSION: This study demonstrated that a significant proportion of the study samples could not achieve glycaemic targets and the average blood glucose was far higher than the recommended glycaemic target level. Insulin initiation and titration, considering the determinants of glycaemic control, could be recommended to achieve target glycaemic levels. BMJ Publishing Group 2022-09-07 /pmc/articles/PMC9454077/ /pubmed/36691186 http://dx.doi.org/10.1136/bmjopen-2022-065250 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Diabetes and Endocrinology
Sendekie, Ashenafi Kibret
Belachew, Eyayaw Ashete
Dagnew, Ephrem Mebratu
Netere, Adeladlew Kassie
Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study
title Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study
title_full Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study
title_fullStr Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study
title_full_unstemmed Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study
title_short Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study
title_sort rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in northwest ethiopia: a multicentre cross-sectional study
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454077/
https://www.ncbi.nlm.nih.gov/pubmed/36691186
http://dx.doi.org/10.1136/bmjopen-2022-065250
work_keys_str_mv AT sendekieashenafikibret rateofglycaemiccontrolandassociatedfactorsinpatientswithtype2diabetesmellitustreatedwithinsulinbasedtherapyatselectedhospitalsinnorthwestethiopiaamulticentrecrosssectionalstudy
AT belacheweyayawashete rateofglycaemiccontrolandassociatedfactorsinpatientswithtype2diabetesmellitustreatedwithinsulinbasedtherapyatselectedhospitalsinnorthwestethiopiaamulticentrecrosssectionalstudy
AT dagnewephremmebratu rateofglycaemiccontrolandassociatedfactorsinpatientswithtype2diabetesmellitustreatedwithinsulinbasedtherapyatselectedhospitalsinnorthwestethiopiaamulticentrecrosssectionalstudy
AT netereadeladlewkassie rateofglycaemiccontrolandassociatedfactorsinpatientswithtype2diabetesmellitustreatedwithinsulinbasedtherapyatselectedhospitalsinnorthwestethiopiaamulticentrecrosssectionalstudy